<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>RFK Jr. plans to make 6 unapproved peptides available for temporary sale — Live Feed</title><link>https://www.live-feeds.com/feed/rfk-jr-plans-to-make-6-unapproved-peptides-available-for-temporary-sale</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/rfk-jr-plans-to-make-6-unapproved-peptides-available-for-temporary-sale/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>RFK Jr. allows temporary sale of 6 unapproved peptides</title><link>https://www.live-feeds.com/feed/rfk-jr-plans-to-make-6-unapproved-peptides-available-for-temporary-sale</link><guid isPermaLink="false">https://www.live-feeds.com/feed/rfk-jr-plans-to-make-6-unapproved-peptides-available-for-temporary-sale#u166714</guid><pubDate>Sun, 01 Nov 2026 04:18:11 +0000</pubDate><description>US Health Secretary RFK Jr. is allowing the temporary sale of six unapproved peptides, bypassing FDA approval. This decision enables certain pharmacies to compound and dispense these peptides immediately. The move has raised concerns among health experts due to the lack of clinical trials and unknown long-term effects.Why it mattersThe peptides in question are popular but have not undergone thorough clinical trials for human use. RFK Jr.&amp;#039;s decision affects how these substances are regulated and accessed. This change has implications for public health and the pharmaceutical industry.What i</description></item>
</channel></rss>